evidence card · semaglutide_mental_health_benefit
GLP-1 receptor agonists improve mental health outcomes (depression/anxiety) in diabetic/obese populations
H3
≈ mixed
stakes moderate
0 posts scored
·
across 0 accounts
·
1 sources
Summary
Large Swedish cohort work suggests protective association; RCT data are limited. FDA retained a warning during suicide-ideation review in 2024 after no clear causal signal emerged, but causation in either direction is not established.
Five-score assessment
Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)
Scope
Population
adults with T2D or obesity
Intervention
GLP-1 RA
Outcome
depression/anxiety incidence or worsening
Not supported for
- causal claims based solely on cohort data; population outside T2D/obesity
Evidence sources
Sources
Account mentions
No accounts have made claims mapped to this card yet.